Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03745118 · ClinicalTrials.gov registry record · NA
Development of a Practical, Minimally Invasive Seizure Gauge
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT03745118: Completed NA study, sponsored by Mayo Clinic.
NCT03745118 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 95 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03745118, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The researchers are trying to assess changes in physiological signals before and during seizures.
Primary Outcome
We will collect physiological signals with the five wearable, noninvasive biosensors listed below in Mayo patients undergoing scalp-recorded video EEG and invasive stereotactic EEG/video monitoring as part of their clinical epilepsy evaluation. We will evaluate biosignals based on data quality and reliability, and subject comfort and ease of use.
Interventions
- DEVICE EpiTel EpiLog
- DEVICE Byte Flies Sensor Dots
- DEVICE Empatica E4
- DEVICE Biovotion Everion
- DEVICE GeneActiv
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2018-11-19 |
| Est. Completion | 2022-08-05 |
| Phase | NA |
What the finished NCT03745118 record still lists
NCT03745118 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 5 interventions - of which EpiTel EpiLog is the first listed.
NCT03745118 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03745118 about?
NCT03745118 is a clinical study titled "Development of a Practical, Minimally Invasive Seizure Gauge". The researchers are trying to assess changes in physiological signals before and during seizures.
What is the current status of trial NCT03745118?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2018-11-19. Estimated completion is 2022-08-05.
What interventions are being tested in trial NCT03745118?
The interventions under investigation include: EpiTel EpiLog (DEVICE), Byte Flies Sensor Dots (DEVICE), Empatica E4 (DEVICE), Biovotion Everion (DEVICE), GeneActiv (DEVICE).
Who is sponsoring clinical trial NCT03745118?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03745118's enrollment target sits among peer trials
95 931st of 2000 higher than 1,066 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI